Atorvastatin and clopidogrel interaction: increased CV risk?

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2006年 / 1114卷 / 1期

关键词：

Statin; Percutaneous Coronary Intervention; Clopidogrel; Atorvastatin; Composite Outcome;

D O I：

10.2165/00128415-200611140-00001

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：1 / 1

相关论文

共 50 条

[21] No increased CV risk with systemic psoriasis therapies?
Reactions Weekly, 2011, 1367 (1) : 3 - 3
[22] Testosterone products: increased risk of CV disorders
Reactions Weekly, 2016, 1588 (1) : 4 - 4
[23] Increased CV-Risk if Breakfast is skipped
Kessing, Richard
AKTUELLE KARDIOLOGIE, 2019, 8 (04) : 262 - +
[24] Tocilizumab: no increased CV risk versus etanercept
Reactions Weekly, 2018, 1685 (1) : 11 - 11
[25] Testosterone therapy: increased risk of CV events
Reactions Weekly, 2014, 1489 (1) : 2 - 2
[26] Celecoxib CV risk increased at higher dosages
Reactions Weekly, 2008, 1197 (1) : 3 - 3
[27] Atorvastatin reduces clopidogrel antiplatelet activity
Reactions Weekly, 2003, 941 (1) : 3 - 3
[28] Atorvastatin may inhibit clopidogrel activity
不详
FORMULARY, 2003, 38 (02) : 83 - 84
[29] Atorvastatin and clopidogrel interfere with photosensitization in vitro
Lee, Dong Kun
Choi, Yongdoo
Shon, Soo-Min
Schellingerhout, Dawid
Park, Jin Eok
Kim, Dong-Eog
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES, 2011, 10 (10) : 1587 - 1592
[30] Atorvastatin and clopidogrel interfere with photosensitization in vitro
Dong Kun Lee
Yongdoo Choi
Soo-Min Shon
Dawid Schellingerhout
Jin Eok Park
Dong-Eog Kim
Photochemical & Photobiological Sciences, 2011, 10 : 1587 - 1592

← 1 2 3 4 5 →